Industry Research Reports
Global Hemoperfusion Market Research Report 2026
Industry: Medical Devices & Consumables
Published Date: 2026-01-04
Pages: 104 Pages
Report ld: 5526315
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hemoperfusion Market Size(US$)
CAGR 2026-2032
8.6%
Market Size,2032
USD 814
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 496 million
Market Forecast in 2032(Value)
US$ 814 million
CAGR
8.6%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Hemoperfusion market was valued at US$ 478 million in 2025 and is anticipated to reach US$ 814 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hemoperfusion competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.In 2025, global Hemoperfusion production reached approximately 7052 K Unit.
Hemoperfusion demand is driven first by clinical need in critical care where standard supportive therapies (ventilation, vasopressors, renal replacement therapy) don’t directly remove circulating toxins or inflammatory mediators. The core use-cases that pull adoption are: acute poisonings/drug intoxications (where removing protein-bound or lipophilic toxins can matter), liver failure and hyperbilirubinemia, and severe systemic inflammation (sepsis/septic shock, pancreatitis, certain post-surgical or trauma inflammatory states) where clinicians aim to reduce circulating cytokines/endotoxin burden. Growth is also supported by rising ICU volumes tied to aging populations and higher prevalence of multi-morbidity (cardiometabolic disease, chronic kidney disease), plus increasing recognition of “adjunctive blood purification” options in settings where mortality remains high despite best-practice bundles.
A second set of drivers is workflow and technology fit: hemoperfusion can be deployed as a stand-alone circuit or integrated with CRRT/ECMO platforms, allowing hospitals to add it without building an entirely new infrastructure. The market is pulled by single-use consumables (cartridges/columns) with predictable ordering patterns once protocols are established, and by product improvements such as higher adsorption capacity, better biocompatibility, lower clotting risk, and more consistent performance across patient conditions. Commercial adoption is strongly influenced by reimbursement coverage, local health-technology assessments, and hospital procurement economics (ICU length-of-stay impact, vasopressor days, dialysis days). Finally, evidence quality is a major gatekeeper: more positive real-world data, better patient-selection criteria, and clearer endpoints (hemodynamic stabilization, organ-support intensity, biomarker kinetics) tend to unlock broader uptake, while mixed trial outcomes can slow it or confine usage to specific indications and regions.
Gross profit margin (industry, short): hemoperfusion is typically a high–gross-margin consumables model (single-use cartridges plus accessories) once scale and yields are stable, because material costs are modest relative to clinical selling price and value is tied to outcomes and compatibility. In practice, margins vary widely by region and competitive intensity, but many established players target roughly ~50–70% gross margin.
This report delivers a comprehensive overview of the global Hemoperfusion market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hemoperfusion. The Hemoperfusion market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Hemoperfusion market comprehensively. Regional market sizes by Type, by Application, by Feature, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Hemoperfusion manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Jianfan Biotech
- Kangbei Medical
- Foshan Boxin (Lily Medical)
- Baxter
- Asahi Kasei
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Activated Carbon Adsorption
- Resin Adsorption
Segment by Application
- Hepatic Encephalopathy
- Certain Autoimmune Diseases
- Drug Overdose
- Specific Intoxications
- Others
Segment by Category
- Plasma Perfusion
- Whole Blood Perfusion
Segment by Division
- Direct Selling
- Distribution
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Feature, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Hemoperfusion manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Hemoperfusion sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Hemoperfusion Market Overview
1.1 Product Definition
1.2 Hemoperfusion by Type
1.2.1 Global Hemoperfusion Market Value by Type: 2025 vs 2032
1.2.2 Activated Carbon Adsorption
1.2.3 Resin Adsorption
1.3 Hemoperfusion by Feature
1.3.1 Global Hemoperfusion Market Value by Feature: 2025 vs 2032
1.3.2 Plasma Perfusion
1.3.3 Whole Blood Perfusion
1.4 Hemoperfusion by Channel
1.4.1 Global Hemoperfusion Market Value by Channel: 2025 vs 2032
1.4.2 Direct Selling
1.4.3 Distribution
1.5 Hemoperfusion by Application
1.5.1 Global Hemoperfusion Market Value by Application: 2025 vs 2032
1.5.2 Hepatic Encephalopathy
1.5.3 Certain Autoimmune Diseases
1.5.4 Drug Overdose
1.5.5 Specific Intoxications
1.5.6 Others
1.6 Global Hemoperfusion Market Size Estimates and Forecasts
1.6.1 Global Hemoperfusion Revenue 2021–2032
1.6.2 Global Hemoperfusion Sales 2021–2032
1.6.3 Global Hemoperfusion Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Hemoperfusion Market Competition by Manufacturers
2.1 Global Hemoperfusion Sales Market Share by Manufacturers (2021–2026)
2.2 Global Hemoperfusion Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Hemoperfusion Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Hemoperfusion, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Hemoperfusion, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Hemoperfusion, Product Types and Applications
2.7 Global Key Manufacturers of Hemoperfusion, Date of Entry into the Industry
2.8 Global Hemoperfusion Market Competitive Situation and Trends
2.8.1 Global Hemoperfusion Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Hemoperfusion Players Market Share by Revenue
2.8.3 Global Hemoperfusion Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hemoperfusion Market Scenario by Region
3.1 Global Hemoperfusion Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Hemoperfusion Sales by Region: 2021–2032
3.2.1 Global Hemoperfusion Sales by Region: 2021–2026
3.2.2 Global Hemoperfusion Sales by Region: 2027–2032
3.3 Global Hemoperfusion Revenue by Region: 2021–2032
3.3.1 Global Hemoperfusion Revenue by Region: 2021–2026
3.3.2 Global Hemoperfusion Revenue by Region: 2027–2032
3.4 North America Hemoperfusion Market Facts & Figures by Country
3.4.1 North America Hemoperfusion Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Hemoperfusion Sales by Country (2021–2032)
3.4.3 North America Hemoperfusion Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemoperfusion Market Facts & Figures by Country
3.5.1 Europe Hemoperfusion Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Hemoperfusion Sales by Country (2021–2032)
3.5.3 Europe Hemoperfusion Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemoperfusion Market Facts & Figures by Region
3.6.1 Asia Pacific Hemoperfusion Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Hemoperfusion Sales by Region (2021–2032)
3.6.3 Asia Pacific Hemoperfusion Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemoperfusion Market Facts & Figures by Country
3.7.1 Latin America Hemoperfusion Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Hemoperfusion Sales by Country (2021–2032)
3.7.3 Latin America Hemoperfusion Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemoperfusion Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemoperfusion Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Hemoperfusion Sales by Country (2021–2032)
3.8.3 Middle East and Africa Hemoperfusion Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemoperfusion Sales by Type (2021–2032)
4.1.1 Global Hemoperfusion Sales by Type (2021–2026)
4.1.2 Global Hemoperfusion Sales by Type (2027–2032)
4.1.3 Global Hemoperfusion Sales Market Share by Type (2021–2032)
4.2 Global Hemoperfusion Revenue by Type (2021–2032)
4.2.1 Global Hemoperfusion Revenue by Type (2021–2026)
4.2.2 Global Hemoperfusion Revenue by Type (2027–2032)
4.2.3 Global Hemoperfusion Revenue Market Share by Type (2021–2032)
4.3 Global Hemoperfusion Price by Type (2021–2032)
5 Segment by Application
5.1 Global Hemoperfusion Sales by Application (2021–2032)
5.1.1 Global Hemoperfusion Sales by Application (2021–2026)
5.1.2 Global Hemoperfusion Sales by Application (2027–2032)
5.1.3 Global Hemoperfusion Sales Market Share by Application (2021–2032)
5.2 Global Hemoperfusion Revenue by Application (2021–2032)
5.2.1 Global Hemoperfusion Revenue by Application (2021–2026)
5.2.2 Global Hemoperfusion Revenue by Application (2027–2032)
5.2.3 Global Hemoperfusion Revenue Market Share by Application (2021–2032)
5.3 Global Hemoperfusion Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Jianfan Biotech
6.1.1 Jianfan Biotech Company Information
6.1.2 Jianfan Biotech Description and Business Overview
6.1.3 Jianfan Biotech Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Jianfan Biotech Hemoperfusion Product Portfolio
6.1.5 Jianfan Biotech Recent Developments/Updates
6.2 Kangbei Medical
6.2.1 Kangbei Medical Company Information
6.2.2 Kangbei Medical Description and Business Overview
6.2.3 Kangbei Medical Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Kangbei Medical Hemoperfusion Product Portfolio
6.2.5 Kangbei Medical Recent Developments/Updates
6.3 Foshan Boxin (Lily Medical)
6.3.1 Foshan Boxin (Lily Medical) Company Information
6.3.2 Foshan Boxin (Lily Medical) Description and Business Overview
6.3.3 Foshan Boxin (Lily Medical) Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Foshan Boxin (Lily Medical) Hemoperfusion Product Portfolio
6.3.5 Foshan Boxin (Lily Medical) Recent Developments/Updates
6.4 Baxter
6.4.1 Baxter Company Information
6.4.2 Baxter Description and Business Overview
6.4.3 Baxter Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Baxter Hemoperfusion Product Portfolio
6.4.5 Baxter Recent Developments/Updates
6.5 Asahi Kasei
6.5.1 Asahi Kasei Company Information
6.5.2 Asahi Kasei Description and Business Overview
6.5.3 Asahi Kasei Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Asahi Kasei Hemoperfusion Product Portfolio
6.5.5 Asahi Kasei Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemoperfusion Industry Chain Analysis
7.2 Hemoperfusion Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemoperfusion Production Mode & Process Analysis
7.4 Hemoperfusion Sales and Marketing
7.4.1 Hemoperfusion Sales Channels
7.4.2 Hemoperfusion Distributors
7.5 Hemoperfusion Customer Analysis
8 Hemoperfusion Market Dynamics
8.1 Hemoperfusion Industry Trends
8.2 Hemoperfusion Market Drivers
8.3 Hemoperfusion Market Challenges
8.4 Hemoperfusion Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Hemoperfusion Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Hemoperfusion Market Value by Feature (US$ Million), 2025 vs 2032
Table 3. Global Hemoperfusion Market Value by Channel (US$ Million), 2025 vs 2032
Table 4. Global Hemoperfusion Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Hemoperfusion Market Competitive Situation by Manufacturers in 2025
Table 6. Global Hemoperfusion Sales (K Units) of Key Manufacturers (2021–2026)
Table 7. Global Hemoperfusion Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Hemoperfusion Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Hemoperfusion Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Hemoperfusion Average Price (USD/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Hemoperfusion, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Hemoperfusion, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Hemoperfusion, Product Types and Applications
Table 14. Global Key Manufacturers of Hemoperfusion, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Hemoperfusion Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hemoperfusion Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Hemoperfusion Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Hemoperfusion Sales by Region (K Units), 2021–2026
Table 20. Global Hemoperfusion Sales Market Share by Region (2021–2026)
Table 21. Global Hemoperfusion Sales by Region (K Units), 2027–2032
Table 22. Global Hemoperfusion Sales Market Share by Region (2027–2032)
Table 23. Global Hemoperfusion Revenue by Region (US$ Million), 2021–2026
Table 24. Global Hemoperfusion Revenue Market Share by Region (2021–2026)
Table 25. Global Hemoperfusion Revenue by Region (US$ Million), 2027–2032
Table 26. Global Hemoperfusion Revenue Market Share by Region (2027–2032)
Table 27. North America Hemoperfusion Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Hemoperfusion Sales by Country (K Units), 2021–2026
Table 29. North America Hemoperfusion Sales by Country (K Units), 2027–2032
Table 30. North America Hemoperfusion Revenue by Country (US$ Million), 2021–2026
Table 31. North America Hemoperfusion Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Hemoperfusion Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Hemoperfusion Sales by Country (K Units), 2021–2026
Table 34. Europe Hemoperfusion Sales by Country (K Units), 2027–2032
Table 35. Europe Hemoperfusion Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Hemoperfusion Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Hemoperfusion Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Hemoperfusion Sales by Region (K Units), 2021–2026
Table 39. Asia Pacific Hemoperfusion Sales by Region (K Units), 2027–2032
Table 40. Asia Pacific Hemoperfusion Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Hemoperfusion Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Hemoperfusion Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Hemoperfusion Sales by Country (K Units), 2021–2026
Table 44. Latin America Hemoperfusion Sales by Country (K Units), 2027–2032
Table 45. Latin America Hemoperfusion Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Hemoperfusion Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Hemoperfusion Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Hemoperfusion Sales by Country (K Units), 2021–2026
Table 49. Middle East and Africa Hemoperfusion Sales by Country (K Units), 2027–2032
Table 50. Middle East and Africa Hemoperfusion Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Hemoperfusion Revenue by Country (US$ Million), 2027–2032
Table 52. Global Hemoperfusion Sales (K Units) by Type (2021–2026)
Table 53. Global Hemoperfusion Sales (K Units) by Type (2027–2032)
Table 54. Global Hemoperfusion Sales Market Share by Type (2021–2026)
Table 55. Global Hemoperfusion Sales Market Share by Type (2027–2032)
Table 56. Global Hemoperfusion Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Hemoperfusion Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Hemoperfusion Revenue Market Share by Type (2021–2026)
Table 59. Global Hemoperfusion Revenue Market Share by Type (2027–2032)
Table 60. Global Hemoperfusion Price (USD/Unit) by Type (2021–2026)
Table 61. Global Hemoperfusion Price (USD/Unit) by Type (2027–2032)
Table 62. Global Hemoperfusion Sales (K Units) by Application (2021–2026)
Table 63. Global Hemoperfusion Sales (K Units) by Application (2027–2032)
Table 64. Global Hemoperfusion Sales Market Share by Application (2021–2026)
Table 65. Global Hemoperfusion Sales Market Share by Application (2027–2032)
Table 66. Global Hemoperfusion Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Hemoperfusion Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Hemoperfusion Revenue Market Share by Application (2021–2026)
Table 69. Global Hemoperfusion Revenue Market Share by Application (2027–2032)
Table 70. Global Hemoperfusion Price (USD/Unit) by Application (2021–2026)
Table 71. Global Hemoperfusion Price (USD/Unit) by Application (2027–2032)
Table 72. Jianfan Biotech Company Information
Table 73. Jianfan Biotech Description and Business Overview
Table 74. Jianfan Biotech Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 75. Jianfan Biotech Hemoperfusion Product
Table 76. Jianfan Biotech Recent Developments/Updates
Table 77. Kangbei Medical Company Information
Table 78. Kangbei Medical Description and Business Overview
Table 79. Kangbei Medical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 80. Kangbei Medical Hemoperfusion Product
Table 81. Kangbei Medical Recent Developments/Updates
Table 82. Foshan Boxin (Lily Medical) Company Information
Table 83. Foshan Boxin (Lily Medical) Description and Business Overview
Table 84. Foshan Boxin (Lily Medical) Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 85. Foshan Boxin (Lily Medical) Hemoperfusion Product
Table 86. Foshan Boxin (Lily Medical) Recent Developments/Updates
Table 87. Baxter Company Information
Table 88. Baxter Description and Business Overview
Table 89. Baxter Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 90. Baxter Hemoperfusion Product
Table 91. Baxter Recent Developments/Updates
Table 92. Asahi Kasei Company Information
Table 93. Asahi Kasei Description and Business Overview
Table 94. Asahi Kasei Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 95. Asahi Kasei Hemoperfusion Product
Table 96. Asahi Kasei Recent Developments/Updates
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Hemoperfusion Distributors List
Table 100. Hemoperfusion Customers List
Table 101. Hemoperfusion Market Trends
Table 102. Hemoperfusion Market Drivers
Table 103. Hemoperfusion Market Challenges
Table 104. Hemoperfusion Market Restraints
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hemoperfusion
Figure 2. Global Hemoperfusion Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Hemoperfusion Market Share by Type: 2025 & 2032
Figure 4. Activated Carbon Adsorption Product Picture
Figure 5. Resin Adsorption Product Picture
Figure 6. Global Hemoperfusion Market Value by Feature (US$ Million), 2021–2032
Figure 7. Global Hemoperfusion Market Share by Feature: 2025 vs 2032
Figure 8. Plasma Perfusion Product Picture
Figure 9. Whole Blood Perfusion Product Picture
Figure 10. Global Hemoperfusion Market Value by Channel (US$ Million), 2021–2032
Figure 11. Global Hemoperfusion Market Share by Channel: 2025 vs 2032
Figure 12. Direct Selling Product Picture
Figure 13. Distribution Product Picture
Figure 14. Global Hemoperfusion Market Value by Application (US$ Million), 2021–2032
Figure 15. Global Hemoperfusion Market Share by Application: 2025 & 2032
Figure 16. Hepatic Encephalopathy
Figure 17. Certain Autoimmune Diseases
Figure 18. Drug Overdose
Figure 19. Specific Intoxications
Figure 20. Others
Figure 21. Global Hemoperfusion Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Hemoperfusion Market Size (US$ Million), 2021–2032
Figure 23. Global Hemoperfusion Sales (K Units), 2021–2032
Figure 24. Global Hemoperfusion Average Price (USD/Unit), 2021–2032
Figure 25. Hemoperfusion Report Years Considered
Figure 26. Hemoperfusion Sales Share by Manufacturers in 2025
Figure 27. Global Hemoperfusion Revenue Share by Manufacturers in 2025
Figure 28. Top 5 and Top 10 Global Hemoperfusion Players: Market Share by Revenue in Hemoperfusion in 2025
Figure 29. Hemoperfusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 30. Global Hemoperfusion Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 31. North America Hemoperfusion Sales Market Share by Country (2021–2032)
Figure 32. North America Hemoperfusion Revenue Market Share by Country (2021–2032)
Figure 33. U.S. Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Canada Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Europe Hemoperfusion Sales Market Share by Country (2021–2032)
Figure 36. Europe Hemoperfusion Revenue Market Share by Country (2021–2032)
Figure 37. Germany Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. France Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. U.K. Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Italy Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Russia Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Asia Pacific Hemoperfusion Sales Market Share by Region (2021–2032)
Figure 43. Asia Pacific Hemoperfusion Revenue Market Share by Region (2021–2032)
Figure 44. China Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Japan Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. South Korea Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. India Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Australia Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. China Taiwan Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Indonesia Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Thailand Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Malaysia Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Latin America Hemoperfusion Sales Market Share by Country (2021–2032)
Figure 54. Latin America Hemoperfusion Revenue Market Share by Country (2021–2032)
Figure 55. Mexico Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Brazil Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Argentina Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Middle East and Africa Hemoperfusion Sales Market Share by Country (2021–2032)
Figure 59. Middle East and Africa Hemoperfusion Revenue Market Share by Country (2021–2032)
Figure 60. Turkey Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Saudi Arabia Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. UAE Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Global Sales Market Share of Hemoperfusion by Type (2021–2032)
Figure 64. Global Revenue Market Share of Hemoperfusion by Type (2021–2032)
Figure 65. Global Hemoperfusion Price (USD/Unit) by Type (2021–2032)
Figure 66. Global Sales Market Share of Hemoperfusion by Application (2021–2032)
Figure 67. Global Revenue Market Share of Hemoperfusion by Application (2021–2032)
Figure 68. Global Hemoperfusion Price (USD/Unit) by Application (2021–2032)
Figure 69. Hemoperfusion Value Chain
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 8.6% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Hemoperfusion in 2026?
Which companies rank high in the global Hemoperfusion market?
What was the global market size of Hemoperfusion in 2032?
What is the annual compound growth rate of the global Hemoperfusion market size from 2026 to 2032?
Related Reports
Global Hemoperfusion Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemoperfusion market size was US$ 478 million in 2025 and is forecast to reach a readjusted size of US$ 814 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 67
USD 4250.00
(Single User License)
Hemoperfusion- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemoperfusion was estimated to be worth US$ 478 million in 2025 and is projected to reach US$ 814 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 82
USD 3950.00
(Single User License)
Global Hemoperfusion Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemoperfusion market is projected to grow from US$ 697 million in 2024 to US$ 2199 million by 2031, at a CAGR of 18.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-10
Pages: 120
USD 4900.00
(Single User License)
Global Hemoperfusion Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemoperfusion market size was US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 74
USD 4250.00
(Single User License)
Hemoperfusion - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemoperfusion was estimated to be worth US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published Date: 2025-07-02
Pages: 84
USD 3950.00
(Single User License)
Global Hemoperfusion Market Insights, Forecast to 2031
The global Hemoperfusion market is projected to grow from US$ 811 million in 2025 to US$ 2199 million by 2031, at a Compound Annual Growth Rate (CAGR) of 18.1% during the forecast period.
Published Date: 2025-07-02
Pages: 118
USD 4900.00
(Single User License)
Global Hemoperfusion Market Research Report 2025
The global market for Hemoperfusion was valued at US$ 697 million in the year 2024 and is projected to reach a revised size of US$ 2199 million by 2031, growing at a CAGR of 18.1% during the forecast period.
Published Date: 2025-07-02
Pages: 72
USD 2900.00
(Single User License)
Global Hemoperfusion Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemoperfusion was estimated to be worth US$ 697 million and is forecast to reach approximately US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 130
USD 5900.00
(Single User License)
Hemoperfusion- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemoperfusion was estimated to be worth US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 100
USD 3950.00
(Single User License)
Global Hemoperfusion Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
Published Date: 2024-04-17
Pages: 135
USD 5600.00
(Single User License)
Global Hemoperfusion Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemoperfusion market size was US$ 478 million in 2025 and is forecast to reach a readjusted size of US$ 814 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 67
USD 4250.00 (Single User License)Hemoperfusion- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemoperfusion was estimated to be worth US$ 478 million in 2025 and is projected to reach US$ 814 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 82
USD 3950.00 (Single User License)Global Hemoperfusion Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemoperfusion market is projected to grow from US$ 697 million in 2024 to US$ 2199 million by 2031, at a CAGR of 18.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-10
Pages: 120
USD 4900.00 (Single User License)Global Hemoperfusion Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemoperfusion market size was US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 74
USD 4250.00 (Single User License)Hemoperfusion - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemoperfusion was estimated to be worth US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published: 2025-07-02
Pages: 84
USD 3950.00 (Single User License)Global Hemoperfusion Market Insights, Forecast to 2031
The global Hemoperfusion market is projected to grow from US$ 811 million in 2025 to US$ 2199 million by 2031, at a Compound Annual Growth Rate (CAGR) of 18.1% during the forecast period.
Published: 2025-07-02
Pages: 118
USD 4900.00 (Single User License)Global Hemoperfusion Market Research Report 2025
The global market for Hemoperfusion was valued at US$ 697 million in the year 2024 and is projected to reach a revised size of US$ 2199 million by 2031, growing at a CAGR of 18.1% during the forecast period.
Published: 2025-07-02
Pages: 72
USD 2900.00 (Single User License)Global Hemoperfusion Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemoperfusion was estimated to be worth US$ 697 million and is forecast to reach approximately US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 130
USD 5900.00 (Single User License)Hemoperfusion- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemoperfusion was estimated to be worth US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 100
USD 3950.00 (Single User License)Global Hemoperfusion Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
Published: 2024-04-17
Pages: 135
USD 5600.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now